Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Jang, Bo Gun ^a   Lee, Byung Lan ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPHRIN RECEPTOR B2; G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; PROTEIN OLFM4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ASCL2; UNCLASSIFIED DRUG; WNT PROTEIN;

AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER STEM CELL; CARCINOGENESIS; CELL LABELING; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EARLY CANCER; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; LGR5 GENE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH ADENOMA; STOMACH ANTRUM; STOMACH CARCINOMA; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 84892403903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082390     Document Type: Article

References (46)

1. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
2. Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66: 1883-1890; discussion 1895-1886.
3. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.
4. Yan KS, Chia LA, Li X, Ootani A, Su J, et al. (2012) The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A 109: 466-471.
5. Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, et al. (2009) Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136: 2187-2194 e2181.
6. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
7. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, et al. (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337: 730-735.
8. Leushacke M, Barker N (2012) Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 31: 3009-3022.
9. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, et al. (2010) Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6: 25-36.
10. von Rahden BH, Kircher S, Lazariotou M, Reiber C, Stuermer L, et al. (2011) LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus? J Exp Clin Cancer Res 30: 23.
11. Simon E, Petke D, Boger C, Behrens HM, Warneke V, et al. (2012) The spatial distribution of LGR5+ cells correlates with gastric cancer progression. PLoS One 7: e35486.
12. Becker L, Huang Q, Mashimo H (2008) Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal 8: 1168-1176.
13. Wang T, Yeoh KG, Salto-Tellez M (2012) Lgr5 expression is absent in human premalignant lesions of the stomach. Gut 61: 1777-1778.
14. Lewis A, Segditsas S, Deheragoda M, Pollard P, Jeffery R, et al. (2010) Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5. Gut 59: 1680-1686.
15. Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, et al. (2010) Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci 101: 1731-1737.
16. Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, et al. (2008) Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol 98: 124-129.
17. Namikawa T, Hanazaki K (2010) Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol 16: 4634-4639.
18. Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, et al. (2010) Multicentre validation study of nucleic acids extraction from FFPE tissues. Virchows Arch 457: 309-317.
19. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, et al. (2008) Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat genet 40: 1291-1299.
20. Wang F, Flanagan J, Su N, Wang LC, Bui S, et al. (2012) RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14: 22-29.
21. Tanese K, Fukuma M, Yamada T, Mori T, Yoshikawa T, et al. (2008) G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am J Pathol 173: 835-843.
22. Yuasa Y (2003) Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3: 592-600.
23. Mizrak D, Brittan M, Alison M (2008) CD133: molecule of the moment. J Pathol 214: 3-9.
24. Abraham SC, Montgomery EA, Singh VK, Yardley JH, Wu TT (2002) Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 26: 1276-1285.
25. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, et al. (2002) Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161: 611-618.
26. Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, et al. (2011) Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol 18: 1166-1174.
27. Fan XS, Wu HY, Yu HP, Zhou Q, Zhang YF, et al. (2010) Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Colorectal Dis 25: 583-590.
28. Merlos-Suarez A, Barriga FM, Jung P, Iglesias M, Cespedes MV, et al. (2011) The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8: 511-524.
29. Uehara T, Ma D, Yao Y, Lynch JP, Morales K, et al. (2013) H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci 58: 140-149.
30. Wu C, Xie Y, Gao F, Wang Y, Guo Y, et al. (2013) Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. Gene 525: 18-25.
31. Nakata S, Campos B, Bageritz J, Bermejo JL, Becker N, et al. (2013) LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol 23: 60-72.
32. Leedham SJ, Rodenas-Cuadrado P, Howarth K, Lewis A, Mallappa S, et al. (2013) A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut 62: 83-93.
33. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108: 11452-11457.
34. Ruffner H, Sprunger J, Charlat O, Leighton-Davies J, Grosshans B, et al. (2012) R-Spondin potentiates Wnt/beta-catenin signaling through orphan receptors LGR4 and LGR5. PLoS One 7: e40976.
35. Qiao XT, Gumucio DL (2011) Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol 46: 855-865.
36. Tian H, Biehs B, Warming S, Leong KG, Rangell L, et al. (2011) A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478: 255-259.
37. Nam KT, O'Neal RL, Coffey RJ, Finke PE, Barker N, et al. (2011) Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells. Gut 61: 1678-1685.
38. Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, et al. (2010) Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 139: 2028-2037 e2029.
39. Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, et al. (2010) The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol 177: 1514-1533.
40. Capoccia BJ, Jin RU, Kong YY, Peek RM, Jr., Fassan M, et al. (2013) The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest 123: 1475-1491.
41. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, et al. (2011) Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469: 415-418.
42. Farin HF, Van Es JH, Clevers H (2012) Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 143: 1518-1529 e1517.
43. Rothenberg ME, Nusse Y, Kalisky T, Lee JJ, Dalerba P, et al. (2012) Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. Gastroenterology 142: 1195-1205 e1196.
44. Kim TH, Escudero S, Shivdasani RA (2012) Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc Natl Acad Sci U S A 109: 3932-3937.
45. Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, et al. (2004) Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 64: 7740-7747.
46. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.